Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Al Ghurair Investment is a prominent diversified family-owned conglomerate based in the United Arab Emirates with a significant presence in the healthcare and pharmaceutical sectors. Through its healthcare division, Al Ghurair Health, the company operates state-of-the-art pharmaceutical manufacturing facilities in Dubai Industrial City. The company focuses on the production of high-quality generic medications across various therapeutic areas, including cardiology, gastroenterology, and metabolic disorders. Al Ghurair is committed to enhancing regional healthcare self-sufficiency by providing essential medicines and advanced medical services to the MENA region. In addition to manufacturing, the company engages in strategic partnerships with global healthcare providers to manage medical facilities and distribution networks. Their facilities are built to international standards, including GMP certification, ensuring the delivery of safe and effective pharmaceutical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Al Ghurair.